private label Archives - CDR – Chain Drug Review

Amazon poses new threat to rivals as it ramps up PL

June 6, 2016 by Mark Baumgartner Amazon, private label, Private Label Manufacturers Association 2016, Issue 06-06-2016, Issues, News

SEATTLE — Amazon.com Inc. reportedly is set to begin rolling out a broadly expanded lineup of private label brands as the company aims to burnish its reputation as a lower-cost retailer and bolster its efforts to sell more perishable goods. Amazon’s private label offerings will be available only to Amazon Prime members, The Wall Street

Store-brand sales edge up at drug stores

March 31, 2015 by Chain Drug Review and Chain Drug Review 2015 Private Label Yearbook, drug stores, PLMA, private label, Private Label Manufacturers Association, store brands Featured Articles, Leading Headlines, Retail News

NEW YORK — Store-brand dollar sales and share at drug stores rose to a new high in 2014, according to the Private Label Manufacturers Association. Private-brand dollar share grew to 16.5% at drug stores last year on total private-label sales of $8.3 billion, PLMA said Tuesday in releasing its 2015 Private Label Yearbook. Dollar volume